Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Psoriasis (PsO)”

65 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 65 results

Large-scale testing (Phase 3)Not Yet RecruitingNCT06863493
What this trial is testing

Comparison of Otezla to SFA-002 to Placebo in Plaque Psoriasis Patients

Who this might be right for
Psoriasis (PsO)
SFA Therapeutics 125
Early research (Phase 1)Looking for participantsNCT06982352
What this trial is testing

Safety and Pharmacokinetics of LPX-TI641 in Atopic Dermatitis and Psoriasis

Who this might be right for
Atopic Dermatitis (AD)Psoriasis (PsO)
LAPIX Therapeutics Inc. 48
Not applicableEnded earlyNCT06715254
What this trial is testing

A Real-world Study of Tuberculosis Incidence in AS, PsA, or PsO Patients Treated With Secukinumab in Brazil

Who this might be right for
Tuberculosis
Novartis Pharmaceuticals 152
Not applicableLooking for participantsNCT06382051
What this trial is testing

Modifying PEST for Psoriatic Arthritis Screening

Who this might be right for
Plaque PsoriasisPsoriatic Arthritis
Novartis Pharmaceuticals 502
Large-scale testing (Phase 3)Study completedNCT02489227
What this trial is testing

Comparison of CHS-1420 Versus Humira in Subjects With Chronic Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Coherus Oncology, Inc. 545
Post-approval studies (Phase 4)Looking for participantsNCT07401992
What this trial is testing

Effects of Semaglutide on Clinical Outcomes and Metabolic Inflammation in Psoriasis

Who this might be right for
Psoriasis (PsO)Obesity & OverweightDiabetes Mellitus - Type 2
Hospital Universitario Dr. Jose E. Gonzalez 62
Large-scale testing (Phase 3)Study completedNCT02134210
What this trial is testing

Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Chronic Plaque Psoriasis (PsO)

Who this might be right for
Plaque Psoriasis
Coherus Oncology, Inc. 521
Early research (Phase 1)Study completedNCT07181343
What this trial is testing

A Drug-Drug Interaction Study Between HS-10374 Tablets and Drospirenone and Ethinyl Estradiol Tablets(Yasmin®)

Who this might be right for
Psoriasis (PsO)
Hansoh BioMedical R&D Company 18
Not applicableActive Not RecruitingNCT06952465
What this trial is testing

A Study Comparing the Risk of Serious Infections and Malignancies With Deucravacitinib or Biologics in Japanese Patients With Psoriasis

Who this might be right for
Psoriasis
Bristol-Myers Squibb 2,000
Not applicableStudy completedNCT04428411
What this trial is testing

Study To Evaluate The Impact Of Difficult To Treat Sites On Biological Response In Moderate-To-Severe Plaque Psoriasis(PsO).

Who this might be right for
Plaque Psoriasis
Pfizer 486
Testing effectiveness (Phase 2)Looking for participantsNCT06592274
What this trial is testing

HB0017 in Psoriasis Patients

Who this might be right for
Psoriasis (PsO)
Huabo Biopharm Co., Ltd. 200
Post-approval studies (Phase 4)Looking for participantsNCT06857942
What this trial is testing

Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

Who this might be right for
PsoriasisOverweight or Obesity
Eli Lilly and Company 200
Large-scale testing (Phase 3)Study completedNCT03536884
What this trial is testing

Evaluate the Efficacy and Safety of Bimekizumab Compared to an Active Comparator in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Chronic Plaque PsoriasisModerate to Severe Chronic Plaque Psoriasis
UCB Biopharma SRL 743
Large-scale testing (Phase 3)Active Not RecruitingNCT06550076
What this trial is testing

TAK-279 in Participants With Moderate-to-Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Takeda 1,950
Early research (Phase 1)Study completedNCT04163016
What this trial is testing

A Study in Pregnant Women With Chronic Inflammatory Diseases Treated With Cimzia (Certolizumab Pegol)

Who this might be right for
Rheumatoid ArthritisPsoriatic ArthritisCrohn's Disease+2 more
UCB Biopharma SRL 22
Not applicableNot Yet RecruitingNCT07351448
What this trial is testing

Research on the Extraction of Tongue and Facial Diagnosis Features of Psoriasis Vulgaris in Traditional Chinese Medicine and Its Correlation With Laboratory Indicators

Who this might be right for
Psoriasis (PsO)Traditional Chinese Medicine (TCM)Diagnosis
Shanghai Yueyang Integrated Medicine Hospital 450
Large-scale testing (Phase 3)Enrolling By InvitationNCT06982196
What this trial is testing

Sulodexide in Controlling the Recurrence of Psoriasis

Who this might be right for
Psoriasis (PsO)Randomised Controlled Trial
Xijing Hospital 160
Large-scale testing (Phase 3)Study completedNCT02346240
What this trial is testing

Efficacy and Safety Study of Certolizumab Pegol (CZP) Versus Active Comparator and Placebo in Subjects With Plaque Psoriasis (PSO)

Who this might be right for
PsoriasisPlaque Psoriasis
UCB Biopharma S.P.R.L. 559
Post-approval studies (Phase 4)Study completedNCT01587755
What this trial is testing

Optimising Outpatient Care in Mild to Moderate Psoriasis (PSO-TOP)

Who this might be right for
Mild to Moderate Psoriasis
Kristian Reich, MD 1,852
Not applicableNot Yet RecruitingNCT07390487
What this trial is testing

The Effects of Audio-Based Therapy on Anxiety in Psoriasis

Who this might be right for
Psoriasis (PsO)Anxiety
University of California, San Francisco 120
Load More Results